HeartBeam (HeartBeam) Growth Rank : 0 (As of May. 12, 2024)

View and export this data going back to 2021. Start your Free Trial

What is HeartBeam Growth Rank?

HeartBeam has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

HeartBeam Growth Rank Related Terms

Thank you for viewing the detailed overview of HeartBeam's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

HeartBeam (HeartBeam) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HeartBeam Inc (NAS:BEAT) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

2118 Walsh Avenue, Suite 210, Santa Clara, CA, USA, 95050

Website

https://www.heartbeam.com

HeartBeam Inc is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Its initial focus is providing diagnostic data to help physicians with the care management of patients with cardiovascular disease.

Executives

Urioste George De	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Kenneth Harry Persen	officer: Chief Technology Officer	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Robert Paul Eno	officer: President	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 95050
Michael R Jaff	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Mark E Strome	10 percent owner	100 WILSHIRE BLVD, 15TH FL, SANTA MONICA CA 90401
Nelson Kenneth Warwick Iii	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Richard D Brounstein	officer: Chief Financial Officer	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Alan Baumel	officer: Chief Operating Officer	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 94050
Marga Ortigas-wedekind	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Richard M Ferrari	director, officer: Exec Chm of the BOD	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Branislav Vajdic	10 percent owner, officer: Chief Executive Officer	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Willhem Elfrink	director	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 95050
Jon Patrick Hunt	officer: Chief Business Officer	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 95050